Successful treatment of inoperable recurrent secondary hyperparathyroidism with cinacalcet HCl

Author： Eriguchi Rieko Umakoshi Junko Tominaga Yoshihiro Sato Yuzuru

ISSN： 1753-0784

Source： NDT PLUS, Vol.1, Iss.4, 2008-08, pp. : 218-220

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cinacalcet as alternative treatment for primary hyperparathyroidism: achievements and prospects

By Duntas Leonidas

Endocrine, Vol. 39, Iss. 3, 2011-06 ,pp. : 199-204

Springer Publishing Company

Access to resources Recommend Favorite

Cinacalcet HCl Suppresses Cyclin D1 Oncogene-Derived Parathyroid Cell Proliferation in a Murine Model for Primary Hyperparathyroidism

By Imanishi Yasuo

Calcified Tissue International, Vol. 89, Iss. 1, 2011-07 ,pp. : 29-35

Springer Publishing Company

Access to resources Recommend Favorite

Prolonged hypocalcaemia following a single dose of 60 mg denosumab in two patients with CKD 4/5 on cinacalcet treatment for tertiary hyperparathyroidism

By Ivanov Petko Khedr Milad

Clinical Kidney Journal, Vol. 6, Iss. 2, 2013-04 ,pp. : 245-245

Oxford University Press

Access to resources Recommend Favorite

Pathogenesis and Treatment of Secondary Hyperparathyroidism in Dialysis Patients: The Role of Paricalcitol

Current Vascular Pharmacology, Vol. 6, Iss. 2, 2008-04 ,pp. : 148-153

Bentham Science Publishers

Access to resources Recommend Favorite

Spotlight on Paricalcitol in Secondary Hyperparathyroidism

By Robinson Dean M. Scott Lesley J.

Treatments in Endocrinology, Vol. 4, Iss. 3, 2005-01 ,pp. : 185-186

Adis International

Access to resources Recommend Favorite